Kressner U - Search Results

1

Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.

Bjørheim J, Lystad S, Lindblom A, Kressner U, Westring S, Wahlberg S, Lindmark G, Gaudernack G, Ekstrøm P, Røe J, Thilly WG, Børresen-Dale AL. Bjørheim J, et al. Among authors: kressner u. Mutat Res. 1998 Jul 17;403(1-2):103-12. doi: 10.1016/s0027-5107(98)00057-8. Mutat Res. 1998. PMID: 9726011

2

Ki-ras mutations and prognosis in colorectal cancer.

Kressner U, Bjørheim J, Westring S, Wahlberg SS, Påhlman L, Glimelius B, Lindmark G, Lindblom A, Børresen-Dale AL. Kressner U, et al. Eur J Cancer. 1998 Mar;34(4):518-21. doi: 10.1016/s0959-8049(97)10111-3. Eur J Cancer. 1998. PMID: 9713302

3

Colorectal cancer with and without microsatellite instability involves different genes.

Salahshor S, Kressner U, Pâhlman L, Glimelius B, Lindmark G, Lindblom A. Salahshor S, et al. Among authors: kressner u. Genes Chromosomes Cancer. 1999 Nov;26(3):247-52. Genes Chromosomes Cancer. 1999. PMID: 10502323

4

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor.

Salahshor S, Kressner U, Fischer H, Lindmark G, Glimelius B, Påhlman L, Lindblom A. Salahshor S, et al. Among authors: kressner u. Br J Cancer. 1999 Sep;81(2):190-3. doi: 10.1038/sj.bjc.6690676. Br J Cancer. 1999. PMID: 10496341 Free PMC article.

5

Missense mutations in hMLH1 associated with colorectal cancer.

Liu T, Tannergård P, Hackman P, Rubio C, Kressner U, Lindmark G, Hellgren D, Lambert B, Lindblom A. Liu T, et al. Among authors: kressner u. Hum Genet. 1999 Nov;105(5):437-41. doi: 10.1007/s004390051127. Hum Genet. 1999. PMID: 10598809

6

Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer.

Lindmark G, Kressner U, Bergström R, Glimelius B. Lindmark G, et al. Among authors: kressner u. Anticancer Res. 1996 Mar-Apr;16(2):895-8. Anticancer Res. 1996. PMID: 8687147

7

Prognostic value of p53 genetic changes in colorectal cancer.

Kressner U, Inganäs M, Byding S, Blikstad I, Påhlman L, Glimelius B, Lindmark G. Kressner U, et al. J Clin Oncol. 1999 Feb;17(2):593-9. doi: 10.1200/JCO.1999.17.2.593. J Clin Oncol. 1999. PMID: 10080604

8

Enzymatic mutation detection in the P53 gene.

Inganäs M, Byding S, Eckersten A, Eriksson S, Hultman T, Jorsback A, Löfman E, Sabounchi F, Kressner U, Lindmark G, Tooke N. Inganäs M, et al. Among authors: kressner u. Clin Chem. 2000 Oct;46(10):1562-73. Clin Chem. 2000. PMID: 11017933

9

Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.

Forslund A, Kressner U, Lindmark G, Inganäs M, Lundholm K. Forslund A, et al. Among authors: kressner u. Int J Oncol. 2001 Sep;19(3):501-6. Int J Oncol. 2001. PMID: 11494027

10

P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.

Forslund A, Kressner U, Lönnroth C, Andersson M, Lindmark G, Lundholm K. Forslund A, et al. Among authors: kressner u. Int J Oncol. 2002 Aug;21(2):409-15. Int J Oncol. 2002. PMID: 12118339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters